...stitute (NHLBI) of the National Institutes of Heal...ng North American clinical trial of diabetes and c...y concerns after review of available data, althoug... to intensively lower blood glucose (sugar) below ...
... mark,its 10th anniversary of delivering identity ...industry, Sentillion, the company that created hea...r-end results. In Q4, Sentillion,added 10 new cust...ity and access management products for single,sign...
...t Increase in Sales from Same ... Greenway Medical Technologies,Inc., a leading pr...R),practice management and interoperability functi...me period in fiscal 2007,and 83 percent from the s...
...out suspected cancer-causing agents, such as deodo...sessment tool has been developed through the Cance...rra Health (SESIH) by a University of New South Wa...y such as using deodorants, artificial sweeteners ...
...es, constructed with soft lithography, should boos...re brain-behavior connections and to screen new ph... infections in humans, report 10 scientists at thr...iled in a paper appearing online ahead of regular ...
...Inc., a global,supplier of infant formulas and nut...anies to accommodate its growing number of interna... into Asia, where it formed PBM,(Guangzhou) Nutrit...007,the magazine,s annual ranking of America,s fas...
Other Medicine News:Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 2Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 3Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 4Health News:Intensive blood sugar treatment in trial of diabetes and cardiovascular disease changed 5Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 2Health News:Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses 3Health News:Greenway Medical Technologies Continues Record Setting Growth 2Health News:Greenway Medical Technologies Continues Record Setting Growth 3Health News:Greenway Medical Technologies Continues Record Setting Growth 4Health News:Reducing cancer panic 2Health News:New devices to boost nematode research on neurons and drugs 2Health News:New devices to boost nematode research on neurons and drugs 3(Date:11/9/2009)...stCall/ -- Volcano Corporation (Nasdaq: VOLC ), a...of products for the diagnosis and treatment of cor...at it will be participating in the Third Annual Ca...mber 10. ,, The presentation by Scott Huenneken...in at 1 p.m., Pacific Standard Time (4 p.m., Easte...
(Date:11/9/2009)...a., Nov. 9 Hill-Rom (N...e formation of a joint venture that will focus on ... of surface replacement systems that are intended ...ements for surfaces that are technologically obsol... a global leader in patient support systems and re...
(Date:11/9/2009)...Asia-FirstCall/ -- American Oriental,Bioengineerin...a pharmaceutical,company dedicated to improving he...ercialization of a broad range of prescription and...d that it plans to release third quarter 2009,fina...the market closes. , The Company will hol...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2Center receives grant renewal for hypertension and vascular disease studies 50659 1Center receives grant renewal for hypertension and vascular disease studies 50659 2...t. 31 United,Therapeutics Corporation (Nasdaq: U...., announced today that they will release the resu... inhaled formulation of treprostinil,in pulmonary ...Thursday,November 1, 2007. United Therapeutics wi... on November 1, 2007, to a full hour to accommodat...
...stal Research,Associates, LLC announced today that...(R) (EIO(R)) on CEL-SCI Corporation (Amex: CVM )....ww.crystalra.com . CEL-SCI Corporation develops i...s. Its primary product candidate is Multikine(R), ...t targets treatment-naive,newly diagnosed head and...
Other Medicine Technology:Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 3